May 15, 2012 — Biotronik Inc., began its U.S. launch of its new Reocor external pacemaker. The device is available in two models, for dual- and single-chamber pacing therapy, and offers individualized patient therapy, easy handling and flexibility in every detail.

 

Sorin Group at the Heart Rhythm Society (HRS) scientific sessions announced U.S. Food and Drug Administration (FDA) approval and commercial launch for a full portfolio of pacing, defibrillation and left ventricular leads. Designed for effective electrical performance and durability, each of the three lead series – Tilda pacing leads, Vigila defibrillation leads and Celerity left ventricular leads – include multiple sizes and features to enable physicians to match their implant preferences with individual patient needs.

 


Patients with the heart rhythm disorder atrial fibrillation (AFib) who received first-line catheter ablation treatment had a longer arrhythmia-free interval than patients receiving anti-arrhythmic drugs, the standard first-line treatment. The preliminary findings were presented during a late-breaking session at the Heart Rhythm Society (HRS) 2012 scientific sessions last week in Boston.

 

May 14, 2012 — Lantheus Medical Imaging Inc. announced new manufacturing and supply agreements with Jubilant HollisterStier LLC (JHS). Under separate agreements, JHS will manufacture Cardiolite (kit for the preparation of technetium Tc99m sestamibi for injection) products and Neurolite (kit for the preparation of technetium Tc99m bicisate for injection), each for an initial term of five years and each with an option to renew for an additional five years thereafter.

May 14, 2012 — GE Healthcare introduced a new version of its Vscan pocket-sized visualization tool, developed to deliver imaging capabilities at the point of care. Based on feedback from current Vscan users, the new version features extended battery life, a more intuitive user interface and enhanced reporting capabilities.

May 14, 2012 — During the Heart Rhythm Society (HRS) 2012 scientific sessions last week, Biosense Webster Inc. announced it created strategic collaboration agreements with GE Healthcare and Siemens Healthcare. The agreements will make it easier for the vendors to work jointly to create advanced electrophysiology (EP) labs

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now